Key Takeaway
This decision highlights an important principle in medicine:
 A drug is only approved as long as its benefits outweigh its risks
In the case of levamisole:
- Risks = neurological complications
- Benefits = treatment of mild conditions
 Result: Withdrawal from the market
Note:
This information is for awareness only and does not replace medical advice. Always consult a healthcare professional for personal guidance.
